New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Aligos Therapeutics, Inc. (ALGS) vs NKGen Biotech, Inc. (NKGN)
- Aligos Therapeutics, Inc. ALGS 1.22 −2.40%
- NKGen Biotech, Inc. NKGN 0.00 NaN
Aligos Therapeutics, Inc. and NKGen Biotech, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and NKGen Biotech, Inc. are of similar size ($8.8M and $8.8M). Across the 8 metrics below, Aligos Therapeutics, Inc. leads on 5 and NKGen Biotech, Inc. on 3.
Valuation
Profitability
| Metric | ALGS | NKGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (215.55%) | — | 0.00% |
| Net margin | (197.01%) | — | 0.00% |
| Free cash flow margin | (204.07%) | — | 0.00% |
| Return on equity | (159.46%) | 44.70% | (51.58%) |
| Return on assets | (84.46%) | (146.49%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack